iRhythm Technologies Inc. (IRTC) saw its stock price plummet 5.06% during intraday trading on Monday, as the market reacted negatively to recent analyst actions.

The decline followed pre-market announcements from two major financial institutions. Truist Securities lowered its price target on iRhythm to $200 from $215, while maintaining a Buy rating on the shares. Separately, Goldman Sachs also reduced its price target, cutting it to $184 from $211, and maintained a Neutral rating on the stock.

Analyst price target reductions are often interpreted by the market as a signal of lowered expectations for a company's future financial performance, which can trigger selling pressure among investors.